Primary and metastatic melanoma of the GI tract: clinical presentation, endoscopic findings, and patient outcomes

被引:0
|
作者
Danielle La Selva
Richard A. Kozarek
Russell K. Dorer
Flavio G. Rocha
Michael Gluck
机构
[1] Digestive Disease Institute,Division of Gastroenterology and Hepatology
[2] Virginia Mason Medical Center,undefined
[3] Digestive Disease Institute,undefined
[4] Virginia Mason Medical Center,undefined
来源
Surgical Endoscopy | 2020年 / 34卷
关键词
Melanoma; Endoscopy; GI Bleeding; Anorectal; Anemia;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4456 / 4462
页数:6
相关论文
共 50 条
  • [21] Treatment Outcomes for Metastatic Melanoma of Unknown Primary in the New Era: A SingleInstitution Study and Review of the Literature
    Utter, Kierstin
    Goldman, Chloe
    Weiss, Sarah A.
    Shapiro, Richard L.
    Berman, Russell S.
    Wilson, Melissa Ann
    Pavlick, Anna C.
    Osman, Iman
    ONCOLOGY, 2017, 93 (04) : 249 - 258
  • [22] Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy
    Lærke K. Tolstrup
    Lars Bastholt
    Ann-Dorthe Zwisler
    Karin B. Dieperink
    Helle Pappot
    Journal of Patient-Reported Outcomes, 3
  • [23] Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy
    Tolstrup, Laerke K.
    Bastholt, Lars
    Zwisler, Ann-Dorthe
    Dieperink, Karin B.
    Pappot, Helle
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2019, 3 (01)
  • [24] Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes
    Emery, Rachel E.
    Stevens, Jeffery S.
    Nance, Robert W.
    Corless, Christopher L.
    Vetto, John T.
    AMERICAN JOURNAL OF SURGERY, 2007, 193 (05): : 618 - 622
  • [25] No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
    Guida, Michele
    Bartolomeo, Nicola
    Quaglino, Pietro
    Madonna, Gabriele
    Pigozzo, Jacopo
    Di Giacomo, Anna M.
    Minisini, Alessandro M.
    Tucci, Marco
    Spagnolo, Francesco
    Occelli, Marcella
    Ridolfi, Laura
    Queirolo, Paola
    De Risi, Ivana
    Quaresmini, Davide
    Gambale, Elisabetta
    Sileni, Vanna Chiaron
    Ascierto, Paolo A.
    Stigliano, Lucia
    Strippoli, Sabino
    CANCERS, 2021, 13 (03) : 1 - 15
  • [26] Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes
    Balinski, Alexander M.
    Vasbinder, Alexi L.
    Kerndt, Connor C.
    Catalan, Tonimarie C.
    Parry, Nathan P.
    Rehman, Rafey A.
    Blakely, Pennelope
    Yeow, Raymond Y.
    Leja, Monika J.
    Lao, Christopher D.
    Fecher, Leslie A.
    Hayek, Salim S.
    CANCER MEDICINE, 2023, 12 (03): : 2356 - 2367
  • [27] Clinical benefit with tebentafusp in a patient with GNAQ mutant metastatic blue nevus-associated melanoma
    Kudelka, Matthew R.
    Richards, Allison L.
    Friedlander, Philip
    Wolchok, Jedd D.
    Moy, Andrea P.
    Shoushtari, Alexander N.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [28] Intramammary metastatic melanoma of unknown primary origin in a 58-year old patient: A case report
    El-Tani Z.
    Duc C.
    Gluecker T.
    Cottier O.
    Journal of Medical Case Reports, 10 (1)
  • [29] Primary melanoma of the esophagus with non-metastatic dark lymph nodes in a female breast cancer patient
    Solari, Nicola
    Acquati, Mirko
    Queirolo, Paola
    Stella, Mattia
    Di Somma, Carmine
    Truini, Mauro
    Cafiero, Ferdinando
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2849 - 2853
  • [30] Clinical characteristics and treatment outcomes of primary malignant melanoma of esophagus: a single center experience
    Tae-Se Kim
    Byung-Hoon Min
    Yang Won Min
    Hyuk Lee
    Poong-Lyul Rhee
    Jae J. Kim
    Jun Haeng Lee
    BMC Gastroenterology, 22